Novocure Operating Cycle from 2010 to 2024

NVCR Stock  USD 19.69  1.81  10.12%   
Novocure Operating Cycle yearly trend continues to be relatively stable with very little volatility. Operating Cycle is likely to grow to 182.60 this year. During the period from 2010 to 2024, Novocure Operating Cycle destribution of quarterly values had range of 142 from its regression line and mean deviation of  35.18. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
152.42732464
Current Value
182.6
Quarterly Volatility
46.4150716
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 3.2 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0 or PTB Ratio of 4.16. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
  
Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Novocure over the last few years. It is Novocure's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Novocure Operating Cycle Regression Statistics

Arithmetic Mean153.60
Geometric Mean147.16
Coefficient Of Variation30.22
Mean Deviation35.18
Median152.43
Standard Deviation46.42
Sample Variance2,154
Range142
R-Value0.42
Mean Square Error1,901
R-Squared0.18
Significance0.11
Slope4.41
Total Sum of Squares30,161

Novocure Operating Cycle History

2024 182.6
2023 152.43
2022 151.89
2021 141.44
2020 165.38
2019 158.78
2018 156.58

About Novocure Financial Statements

Novocure shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 152.43  182.60 

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.